InsidersTradesSigma
Hamlet BioPharma AB Stock: price and insider trades · Finland · FIN-FSA
Track the Hamlet BioPharma AB stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are listed on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Hamlet BioPharma AB has published 1 public disclosures. Market capitalisation: €1.3bn. The latest transaction was reported on 29 March 2026 (Purchase). Among the most active insiders: Marianne Catharina Svanborg. Every trade is free.
1
Insider Decl.
0
Thresholds
€16,127
1 ops.
Buy Volume
·
0 ops.
Sell Volume
16Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 29 March 2026
Declarations1 total
25,000 shares@ €0.64510.0012% mcap100.0% of flowAktieFI:A003X421-1
Ideal exit: 21 Dec 2026 (T+270)
1 of 1 declaration